Milestone Pharmaceuticals, Inc. (MIST)
1.42
-0.02
(-1.39%)
USD |
NASDAQ |
May 29, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
Milestone Pharmaceuticals EPS Diluted (Quarterly) : -0.2001 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -0.7327 |
| NervGen Pharma Corp. | -0.0153 |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | -33.17 |
| Pharmagreen Biotech, Inc. | -0.0017 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.07M |
| Revenue (Quarterly) | 0.238M |
| Total Expenses (Quarterly) | 26.30M |
| Enterprise Value | 129.90M |
| Gross Profit Margin (Quarterly) | 70.59% |
| Profit Margin (Quarterly) | -10.95K% |
| Earnings Yield | -48.08% |
| Normalized Earnings Yield | -48.08 |